Karyopharm Therapeutics Inc. (KPTI) Operating margin 2016–2025
Karyopharm Therapeutics Inc. (KPTI) operating margin by fiscal year — reported operating income divided by reported revenue.
-62.1%FY2025 · since FY2016: -71903.9% → -62.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -62.1% | +20.1 pp |
| FY2024 | -82.2% | +6.5 pp |
| FY2023 | -88.7% | +1.8 pp |
| FY2022 | -90.5% | -43.7 pp |
| FY2021 | -46.8% | +112.2 pp |
| FY2020 | -159.0% | +303.9 pp |
| FY2019 | -462.9% | +130.1 pp |
| FY2018 | -593.0% | +7540.2 pp |
| FY2017 | -8133.2% | +63770.7 pp |
| FY2016 | -71903.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice